title: Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection.
abstract: Serum concentrations of soluble receptors for tumor necrosis factor-alpha (sTNF alpha R) types I and II, beta 2-microglobulin, and CD4 cell counts were determined at entry and 3-5 months before AIDS diagnosis in 20 untreated, asymptomatic human immunodeficiency virus type 1 (HIV-1)-seropositive subjects, who progressed to AIDS within 5.5 years of study entry, and in an equal number of HIV-seronegative and untreated seropositive controls, who remained asymptomatic. At entry, concentrations of sTNF alpha R type II and beta 2-microglobulin were elevated and increased further in progressors. The odds ratio (OR) for sTNF alpha R type II concentrations > or = 6.5 ng/mL was 18.4 and for beta 2-microglobulin concentrations > or = 3 mg/L was 6.6; CD4 cell counts were not predictive. Five months before diagnosis, the OR was 102.0 for sTNF alpha R type II concentrations > or = 7.5 ng/mL, 13.5 for beta 2-microglobulin concentrations > or = 4 mg/L, and 6.9 for CD4 cell counts < 250/mm3 (counts < 500/mm3 were not predictive). Of the three variables, sTNF alpha R type II was proved by bivariate analysis to be the strongest and earliest predictor of disease progression.
authors.affiliation: Department of Internal Medicine, University of Amsterdam, Netherlands.
authors.forename: M H
authors.initials: MH
authors.lastname: Godfried
authors.forename: T
authors.initials: T
authors.lastname: van der Poll
authors.forename: G J
authors.initials: GJ
authors.lastname: Weverling
authors.forename: J W
authors.initials: JW
authors.lastname: Mulder
authors.forename: J
authors.initials: J
authors.lastname: Jansen
authors.forename: S J
authors.initials: SJ
authors.lastname: van Deventer
authors.forename: H P
authors.initials: HP
authors.lastname: Sauerwein
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000209:etiology*; D000328:Adult; D015496:CD4-Positive T-Lymphocytes; D016022:Case-Control Studies; D015331:Cohort Studies; D016001:Confidence Intervals; D005500:Follow-Up Studies; D006679:HIV Seropositivity / Q000276:immunology*; D015497:HIV-1; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D016017:Odds Ratio; D011237:Predictive Value of Tests; D011446:Prospective Studies; D018124:Receptors, Tumor Necrosis Factor / Q000032:analysis*; D012044:Regression Analysis; D013997:Time Factors; D001613:beta 2-Microglobulin / Q000032:analysis
chemical_list: D018124:Receptors, Tumor Necrosis Factor; D001613:beta 2-Microglobulin